Sight Sciences (SGHT) Total Current Liabilities (2020 - 2026)
Sight Sciences' (SGHT) quarterly Total Current Liabilities came in at $18.2 million in Q1 2026, up 49.84% year-on-year from $12.1 million in Q1 2025, and up 64.71% quarter-over-quarter from $11.0 million in Q4 2025.
Sight Sciences (SGHT) Total Current Liabilities (2020 - 2026) Analysis & Trends
Sight Sciences' Total Current Liabilities history runs 7 years deep, the most recent figure standing at $18.2 million for Q1 2026.
- On a quarterly basis, Total Current Liabilities rose 49.84% year-over-year to $18.2 million in Q1 2026; TTM through Mar 2026 was $18.2 million, a 49.84% increase from a year earlier, with the FY2025 full-year figure at $11.0 million, down 28.71% from the prior year.
- Total Current Liabilities climbed to $18.2 million in Q1 2026 per SGHT's latest filing, from $11.0 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $18.2 million in Q1 2026 and bottomed at $11.0 million in Q4 2025.
- The 5-year median for Total Current Liabilities is $13.8 million (2024), against an average of $13.9 million.
- Across the five-year window, Total Current Liabilities jumped 68.55% in 2022 and tumbled 31.23% in 2023, its largest moves.
- Year by year, Total Current Liabilities stood at $17.8 million in 2022, then tumbled by 31.23% to $12.3 million in 2023, then rose by 26.25% to $15.5 million in 2024, then dropped by 28.71% to $11.0 million in 2025, then jumped by 64.71% to $18.2 million in 2026.
- Per Business Quant, the three latest SGHT Total Current Liabilities figures stand at $18.2 million (Q1 2026), $11.0 million (Q4 2025), and $11.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.03 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 128.82 Bn | 125.95 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 108.46 Bn | 99.24 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 68.25 Bn | 66.79 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 28.55 Bn | 27.43 Bn | 750.30 Mn | 2.22 Bn |
| 7 | GE HealthCare Technologies | 28.51 Bn | 26.22 Bn | 1.98 Bn | 8.53 Bn |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - | 1.60 Bn |
| 9 | Koninklijke Philips | 25.42 Bn | 22.29 Bn | 2.07 Bn | 8.70 Bn |
| 10 | Sight Sciences | 282.12 Mn | 197.16 Mn | 16.98 Mn | 18.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.16 Mn |
| Dec 31, 2025 | 11.03 Mn |
| Sep 30, 2025 | 11.83 Mn |
| Jun 30, 2025 | 11.94 Mn |
| Mar 31, 2025 | 12.12 Mn |
| Dec 31, 2024 | 15.47 Mn |
| Sep 30, 2024 | 13.80 Mn |
| Jun 30, 2024 | 13.29 Mn |
| Mar 31, 2024 | 11.69 Mn |
| Dec 31, 2023 | 12.25 Mn |
| Sep 30, 2023 | 14.33 Mn |
| Jun 30, 2023 | 14.05 Mn |
| Mar 31, 2023 | 15.15 Mn |
| Dec 31, 2022 | 17.82 Mn |
| Sep 30, 2022 | 17.39 Mn |
| Jun 30, 2022 | 14.20 Mn |
| Mar 31, 2022 | 12.00 Mn |
| Dec 31, 2021 | 13.50 Mn |
| Sep 30, 2021 | 10.32 Mn |
| Jun 30, 2021 | 12.06 Mn |